We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lorenzo's Oil Prevents Pediatric Disorder

By Biotechdaily staff writers
Posted on 27 Jul 2005
A new study has shown that use of a treatment known as Lorenzo's Oil may prevent a pediatric disorder called x-linked adrenoleukodystrophy (X-ALD) from developing in young boys diagnosed with the disorder but not yet showing signs of it.

The study involved 89 boys, aged seven and younger, who tested positive for an abnormal gene that identifies X-ALD. More...
Over a period of seven years, researchers treated the boys with daily oral doses of Lorenzo's Oil, a combination of two fats extracted from olive oil and rapeseed oil, and moderately restricted their dietary fat. All patients had a normal brain scan and showed no neurologic signs and symptoms of X-ALD prior to the study. At the completion of the study, 74% of the 89 patients showed no signs of disease progression. The researchers correlated greater compliance with a lower risk of developing the disease. This is the first time that the preventive effects of Lorenzo's Oil have been demonstrated by rigorous and scientifically accepted research methods.

X-ALD causes the breakdown of myelin, a fatty substance that acts as an insulator around nerve fibers. Symptoms appear between ages four and 10, and can lead to nerve deterioration, loss of verbal communication, and eventually to complete breakdown of body function.

"This finding is an exciting progression of the research to which my associates and I have dedicated ourselves to help these children,” observed lead author Hugo Moser, M.D., director of the Neurogenetics Research Center at the Kennedy Krieger Institute (Baltimore, MD, USA).

There is still no cure for X-ALD, and treatment options are limited to hormone therapy and bone marrow transplants. Lorenzo's Oil was invented by Augusto and Michaela Odone, whose son, Lorenzo, was diagnosed with X-ALD. Although the oil cannot repair damage already done, it can prevent the disease from progressing into a degenerative state. In spite of the fact that Lorenzo already showed symptoms before taking the oil, the treatment stopped the progression of his disease, and he celebrated his 27th birthday in May 2005. The story of the Odone family's struggle was dramatized in the 1992 motion picture entitled "Lorenzo's Oil.”





Related Links:
Kennedy Krieger Institute

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Automated Urinalysis Solution
UN-9000
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.